Results 131 to 140 of about 1,754 (190)

Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside. [PDF]

J Transl Med
Xu L, Yao S, Ding YE, Xie M, Feng D, Sha P, Tan L, Bei F, Yao Y.   +8 more
europepmc   +1 more source

The adhesion GPCR Gpr56 regulates oligodendrocyte development via interactions with G alpha(12/13) and RhoA [PDF]

, 2015
Ackerman, Sarah D, Garcia, Cynthia, Gutmann, David H, Monk, Kelly R, Piao, Xianhua   +4 more
core   +1 more source

Stem cell and gene therapies for leukodystrophies. [PDF]

Mol Ther Methods Clin Dev
Lin W, Zhang M, Zheng S, Lian Q.
europepmc   +1 more source

Mitochondrial recruitment in myelin: an anchor for myelin dynamics and plasticity? [PDF]

Neural Regen Res
Gothié JM, Kennedy TE.
europepmc   +1 more source

Embryonic origins of forebrain oligodendrocytes revisited by combinatorial genetic fate mapping. [PDF]

Elife
Cai Y, Zhao Z, Shi M, Zheng M, Gong L, He M.   +5 more
europepmc   +1 more source

Progress in AAV-Mediated In Vivo Gene Therapy and Its Applications in Central Nervous System Diseases. [PDF]

Int J Mol Sci
Wang S, Xiao L.
europepmc   +1 more source

mTORopathies in Epilepsy and Neurodevelopmental Disorders: The Future of Therapeutics and the Role of Gene Editing. [PDF]

Cells
Boff MO, Xavier FAC, Diz FM, Gonçalves JB, Ferreira LM, Zambeli J, Pazzin DB, Previato TTR, Erwig HS, Gonçalves JIB, Bruzzo FTK, Marinowic D, da Costa JC, Zanirati G.   +13 more
europepmc   +1 more source

Prenatal Exposure to Tobacco Smoke and Vaping Aerosols: Mechanisms Disrupting White-Matter Formation. [PDF]

Toxics
Beltran-Castillo S, Espinoza JP, Grambs M.   +2 more
europepmc   +1 more source